Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Int J Gynecol Cancer. 2018 Jul;28(6):1077–1084. doi: 10.1097/IGC.0000000000001271

Table 2.

Cost estimates for decision tree analysis of neoadjuvant chemotherapy versus primary debulking surgery for bulky advanced epithelial ovarian cancer

Event PDS NACT Source
Debulking surgery $2,095 $2,095 2015 Medicare Physician Fee Schedule[30]
Additional surgical procedures* $924 $3,907 2015 Medicare Physician Fee Schedule[30]
Surgical hospitalization
 Without complications $11,470 $11,470 HCUPnet[29]
 With major complications $27,030 $27,030 HCUPnet[29]
Readmission for late complication* $5,152 $5,152** HCUPnet[29]
Death $0 $0
Chemotherapy (3 rounds) $1,254 $1,254 2015 ASP[31] + 6%, 2015 Medicare Physician Fee Schedule[30]

Abbreviations: PDS, primary debulking surgery; NACT, neoadjuvant chemotherapy; HCUP, Hospital Cost and Utilization Project; ASP, average sales price

*

Cost was calculated as the weighted average of results reported in Fagotti et al[26]; see Table S1 for individual procedures and probabilities.

**

No late complications were observed among NACT patients in Fagotti et al[26]; the cost of late complications were assumed to be equal to those of PDS when varying this probability in sensitivity analysis.